Conducting observational studies is becoming a vital part of the clinical trial process, but research teams often struggle to operationalize these more creative and non-traditional study methodologies.
Louise Parmenter, PhD
Advertisement
Articles by Louise Parmenter, PhD
Applied Clinical Trials
The adoption of new, consistent definitions are needed to help demystify late phase trials.
Advertisement
Latest Updated Articles
Are Phase Labels Still Relevant?May 1st 2012
- The Observation Study Conundrum
August 29th 2016
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
When There’s No Registry: Building Rare Disease Evidence That Supports Regulatory Scrutiny
2
ACT Brief: Patient-Site Trust Barriers, Rare Disease Evidence Without Registry, and RWD Enrollment Accuracy
3
Trust, Technology, and the Patient-Site Relationship: Q&A with Andrea Valente, uMotif
4
Clinical Site Readiness for Cell and Gene Therapies: Operational and Supply Chain Challenges as they Scale and as they Expand into the Community Care Setting
5